blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0969835

EP0969835 - USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONISTS FOR REGULATING APPETENCY [Right-click to bookmark this link]
Former [2000/02]USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONISTS FOR REGULATING APPETENCE
[2006/46]
StatusNo opposition filed within time limit
Status updated on  08.02.2008
Database last updated on 02.09.2024
Most recent event   Tooltip08.02.2008No opposition filed within time limitpublished on 12.03.2008  [2008/11]
Applicant(s)For all designated states
Sanofi-Aventis
174, Avenue de France
75013 Paris / FR
[2004/44]
Former [2000/02]For all designated states
Sanofi-Synthélabo
174, Avenue de France
75013 Paris / FR
Inventor(s)01 / MARUANI, Jeanne
Lotissement la Colline No. 8
F-34570 Vailhauques / FR
02 / SOUBRIE, Philippe
Le Rey, Valflaunès
F-34270 Saint Mathieu de Tréviers / FR
[2000/02]
Representative(s)Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cédex 07 / FR
[N/P]
Former [2000/02]Gillard, Marie-Louise, et al
Cabinet Beau de Loménie 158, rue de l'Université
75340 Paris Cédex 07 / FR
Application number, filing date98904238.728.01.1998
[2000/02]
WO1998FR00154
Priority number, dateFR1997000087028.01.1997         Original published format: FR 9700870
[2000/02]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9832441
Date:30.07.1998
Language:FR
[1998/30]
Type: A1 Application with search report 
No.:EP0969835
Date:12.01.2000
Language:FR
The application published by WIPO in one of the EPO official languages on 30.07.1998 takes the place of the publication of the European patent application.
[2000/02]
Type: B1 Patent specification 
No.:EP0969835
Date:04.04.2007
Language:FR
[2007/14]
Search report(s)International search report - published on:EP30.07.1998
ClassificationIPC:A61K31/44
[2000/02]
CPC:
A61K31/454 (EP,US); A61K31/00 (EP,US); A61K31/415 (EP,US);
A61K31/445 (EP,US); A61K45/06 (EP,US); A61P25/00 (EP);
A61P25/30 (EP); A61P25/32 (EP); A61P3/00 (EP);
A61P3/04 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/415, A61K2300/00 (EP,US);
A61K31/445, A61K2300/00 (US,EP);
A61K31/454, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/02]
TitleGerman:VERWENDUNG VON ANTAGONISTEN DER ZENTRALEN KANNABINOIDREZEPTOREN ZUR REGULIERUNG VON SUCHTERSCHEINUNGEN[2007/14]
English:USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONISTS FOR REGULATING APPETENCY[2007/14]
French:UTILISATION D' ANTAGONISTES DES RECEPTEURS AUX CANNABINOIDES CENTRAUX POUR REGULER L'APPETENCE[2006/24]
Former [2000/02]VERWENDUNG VON ANTAGONISTEN DER ZENTRALEN KANNABINOIDREZEPTOREN ZUR REGULIERUNG DES APPETITS
Former [2000/02]USE OF CENTRAL CANNABINOID RECEPTOR ANTAGONISTS FOR REGULATING APPETENCE
Former [2000/02]UTILISATION DES ANTAGONISTES DES RECEPTEURS AUX CANNABINOIDES CENTRAUX POUR REGULER L'APPETANCE
Entry into regional phase23.07.1999National basic fee paid 
23.07.1999Designation fee(s) paid 
23.07.1999Examination fee paid 
Examination procedure13.06.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
23.07.1999Amendment by applicant (claims and/or description)
23.07.1999Examination requested  [2000/02]
28.10.2003Despatch of a communication from the examining division (Time limit: M04)
02.03.2004Reply to a communication from the examining division
14.07.2004Despatch of a communication from the examining division (Time limit: M06)
19.01.2005Reply to a communication from the examining division
09.05.2006Date of oral proceedings
18.05.2006Minutes of oral proceedings despatched
02.06.2006Communication of intention to grant the patent
05.10.2006Fee for grant paid
05.10.2006Fee for publishing/printing paid
Divisional application(s)EP07105573.5  / EP1795194
Opposition(s)07.01.2008No opposition filed within time limit [2008/11]
Fees paidRenewal fee
10.01.2000Renewal fee patent year 03
11.01.2001Renewal fee patent year 04
14.01.2002Renewal fee patent year 05
14.01.2003Renewal fee patent year 06
14.01.2004Renewal fee patent year 07
12.01.2005Renewal fee patent year 08
12.01.2006Renewal fee patent year 09
12.01.2007Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]EP0656354  (SANOFI SA [FR]);
 [A]  - D. SHIRE ET AL., "Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A", J. BIOL. CHEM., (1996), vol. 271, no. 12, pages 6941 - 6946, XP002044759

DOI:   http://dx.doi.org/10.1074/jbc.271.12.6941
 [A]  - R. PERTWEE ET AL., "AM630, a competetive cannabinoid receptor antagonist.", LIFE SCI., (1995), vol. 56, no. 23/24, pages 1941 - 1947, XP002044760

DOI:   http://dx.doi.org/10.1016/0024-3205(95)00175-6
 [A]  - M. RINALDI-CARMONA ET AL., "Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor anragonist.", LIFE SCI., (1995), vol. 56, no. 23/24, pages 1949 - 1955, XP002044761

DOI:   http://dx.doi.org/10.1016/0024-3205(95)00174-5
 [A]  - F. BARTH ET AL., "Cannabinoids: receptors, endogenous ligans and a newly synthesized antagonist.", NIDA RES. MONOGRAPH, (1996), vol. 162, pages 52 - 53, XP002044762
 [A]  - M. RINALDI-CARMONA ET AL., "Characterization and distribution of binding sites for [3H]-SR141716A, a selective brain(CB1) cannabinoid receptor antagonist, in rodent brain.", LIFE SCI., (1996), vol. 58, no. 15, pages 1239 - 1247, XP002044763

DOI:   http://dx.doi.org/10.1016/0024-3205(96)00085-9
 [DA]  - M. RINALDI-CARMONA ET AL., "SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.", FEBS LETTERS, (1994), vol. 350, no. 2-3, pages 240 - 244, XP002044764

DOI:   http://dx.doi.org/10.1016/0014-5793(94)00773-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.